Literature DB >> 18342688

Mumps.

Anders Hviid1, Steven Rubin, Kathrin Mühlemann.   

Abstract

Mumps is a common childhood infection caused by the mumps virus. The hallmark of infection is swelling of the parotid gland. Aseptic meningitis and encephalitis are common complications of mumps together with orchitis and oophoritis, which can arise in adult men and women, respectively; other complications include deafness and pancreatitis. Clinical diagnosis can be based on the classic parotid swelling; however, this feature is not present in all cases of mumps and can also occur in various other disorders. Laboratory diagnosis is based on isolation of virus, detection of viral nucleic acid, or serological confirmation (generally presence of IgM mumps antibodies). Mumps is vaccine-preventable, and one dose of mumps vaccine is about 80% effective against the disease. Routine vaccination has proven highly effective in reducing the incidence of mumps, and is presently used by most developed countries; however, there have been outbreaks of disease in vaccinated populations. In 2005, a large epidemic peaked in the UK, and in 2006 the American midwest had several outbreaks. In both countries, the largest proportion of cases was in young adults. In the UK, susceptible cohorts too old to have been vaccinated and too young to have been exposed to natural infections were the primary cause of the mumps epidemic. In the USA, effectiveness and uptake in combination appear not to have been sufficient to obtain herd immunity for mumps in populations such as college students.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342688     DOI: 10.1016/S0140-6736(08)60419-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  137 in total

1.  Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.

Authors:  Maja Markušić; Maja Šantak; Tanja Košutić-Gulija; Mladen Jergović; Renata Jug; Dubravko Forčić
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

Review 2.  Vaccination of healthcare workers: A review.

Authors:  Skerdi Haviari; Thomas Bénet; Mitra Saadatian-Elahi; Philippe André; Pierre Loulergue; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.

Authors:  C Stein Zamir; H Schroeder; H Shoob; N Abramson; G Zentner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Mumps: resurgence of a vanquished virus.

Authors:  Scott D Smith; Ian Gemmill
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

6.  The association between the incidence of mumps and meteorological parameters in Taiwan.

Authors:  Yi-Chien Ho; Bo-Hua Su; Huey-Jen Su; Hsiao-Ling Chang; Chuan-Yao Lin; Huifen Chen; Kow-Tong Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Acupuncture for mumps in children.

Authors:  Jing He; Pengli Jia; Min Zheng; Mingming Zhang; Hua Jiang
Journal:  Cochrane Database Syst Rev       Date:  2015-02-02

8.  Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.

Authors:  Anja Takla; Merle M Böhmer; Christina Klinc; Norbert Kurz; Alice Schaffer; Heribert Stich; Petra Stöcker; Ole Wichmann; Judith Koch
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

9.  Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.

Authors:  Chuanxi Fu; Jianhua Liang; Ming Wang
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

10.  A 176 amino acid polypeptide derived from the mumps virus HN ectodomain shows immunological and biological properties similar to the HN protein.

Authors:  Emma Herrera; Patricia Barcenas; Rubicela Hernández; Alfonso Méndez; Guillermo Pérez-Ishiwara; Blanca Barrón
Journal:  Virol J       Date:  2010-08-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.